Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

by Liting Zhong, Liting Zhong, Dehua Wu, Weiwei Peng, Hailong Sheng, Yazhi Xiao, Xuebing Zhang, Yuli Wang
Published 2021-05-01

ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

by Hailong Sheng, Yazhi Xiao, Zhenru Zhu, Mengying Shen, Peitao Zhou, Zeqin Guo, Wencong Dai, Wanjun Zhang, Jingyuan Sun, Chuanhui Cao
Published 2020-06-01